Tag: cmo

cmo

Latest News

Samsung Biologics' factory in Songdo, Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics reports record-breaking $1.1 billion in revenue in Q3

Samsung Biologics reported record earnings for the third quarter, posting more than 1.6 trillion won ($1.1 billion) in revenue, driven by large-scale contract wins with global pharmaceutical firms and strong sales of biosimilars.

2025.10.28

A Samsung Biologics plant in Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics' manufacturing deals exceed $2.2 billion this year

Samsung Biologics, the biotech arm of Samsung, said Monday that its contract manufacturing organization (CMO) deals have exceeded 3 trillion won ($2.2 billion) so far this year.

2025.5.26

Most popular

A digital render of Samsung Biologics' Plant 5 in Songdo, Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics orders hit 3 trillion won in historic milestone

Samsung Biologics has secured five biomanufacturing contracts, bringing the total of its 2023 orders to over 3 trillion won for the first time since its foundation.

2023.11.28

Samsung Biologics CEO John Rim speaks during a press event at its headquarters in Incheon. [SAMSUNG BIOLOGICS]

Samsung Biologics has blowout Q3, revenues hit new high

Samsung Biologics posted a consensus-beating 320 billion won ($240 million) in operating profit in the third quarter, with revenues surpassing 1 trillion won for the first time in its history.

2023.10.25

Samsung Biologics' fourth plant in Songdo, Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics raises revenue forecast to $2.65 billion

Samsung Biologics raised its revenue forecast for the year to $2.65 billion, citing new contract manufacturing deals and increased production capabilities.

2023.10.4

Samsung Biologics scores $242M Bristol-Myers Squibb deal

Samsung Biologics secures a $242 million contract manufacturing deal with Bristol-Myers Squibb, boosting its total contract wins this year to nearly $2.26 billion.

2023.9.18

John Rim, Samsung Biologics CEO, speaks during a press conference held in Boston on Monday. [YONHAP]

Samsung Biologics signs record CMO deal with Pfizer

Samsung Biologics inked a $411 million contract manufacturing organization (CMO) letter of intent with Pfizer Ireland Pharmaceuticals, the biggest single deal the Korean company ever signed.

2023.6.8

Samsung Biologics’ third plant in Songdo, Incheon [SAMSUNG BIOLOGICS]

Samsung Biologics signs CMO agreement with U.S. company

Samsung Biologics inked a $112.5 million contract manufacturing organization (CMO) letter of intent with an unnamed U.S. biopharmaceutical firm, the Korean company said in a regulatory filing on Monday.

2023.6.5